Cuộc họp báo cáo kết quả kinh doanh quý 1 năm tài chính 2027 của Cardinal Health (CAH): Nâng định hướng EPS
Doanh thu quý 1 năm tài chính 2027 của Cardinal Health tăng 5% lên 67,5 tỷ USD, EPS tăng 28%, đồng thời ban lãnh đạo đã nâng định hướng EPS cả năm lên mức 12,80-13,00 USD.
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.